Standards for clinical practice guidance. by unknown
NATIONAL
CLINICAL
EFFECTI ENESS
COMMITTEE
National Clinical Effectiveness Committee 
Standards for Clinical Practice Guidance
November 2015
Table of Contents
Glossary of Terms  2
1. Purpose  4
2.  Scope  5
3.  Monitoring and Implementation 6
4.  Expert advisory group 7
5.  National Clinical Effectiveness Committee 8
6.  Standards for Clinical Practice Guidance – rationale 11
7.  Development of Clinical Practice Guidance 12
References  17
Appendix A
Systematic literature review 19
Appendix B
International resources 21
Appendix C
Building a Culture of Patient Safety 22
Appendix D
Definitions/nomenclature	 23
  @NCECIreland
		www.health.gov.ie/patient-safety/ncec
2 | Standards for Clinical Practice Guidance | National Clinical Effectiveness Committee
Clinical Practice 
Guidance
Clinical	Practice	Guidance	is	defined	as	systematically	developed	statements	
or processes to assist clinician and patient decisions about appropriate health 
care	for	specific	clinical	circumstances,	with	the	type	of	clinical	practice	
guidance	determined	by	evidence-based	criteria	and	clinical	requirements.	
Such	clinical	guidance	includes	clinical	policies,	procedures,	protocols	and	
guidelines.
Clinical Guideline Clinical	Guidelines	are	systematically	developed	statements,	based	on	
a	thorough	evaluation	of	the	evidence,	to	assist	practitioner	and	patient	
decisions	about	appropriate	health	care	for	specific	clinical	circumstances,	
across the entire clinical spectrum. 
NCEC National Clinical 
Guideline
NCEC National Clinical Guidelines are a suite of guidelines that meet 
specific	prioritisation	and	quality	assurance	criteria	and	that	have	been	
recommended by the National Clinical Effectiveness Committee (NCEC).
Once a National Clinical Guideline is endorsed it supersedes any other 
guidelines on that topic. 
Clinical Audit Clinical Audit is a cyclical process that aims to improve patient care and 
outcomes	by	systematic,	structured	review	and	evaluation	of	clinical	care	
against explicit clinical standards.1
NCEC National Clinical 
Audit 
NCEC National Clinical Audits are national audits which have been prioritised 
and	quality	assured	by	the	National	Clinical	Effectiveness	Committee	(NCEC).
Clinical Policy A Clinical Policy is a written operational statement of intent which helps staff 
to	make	appropriate	decisions	and	take	actions,	consistent	with	the	aims	of	
the service provider and in the best interests of service users.
Clinical Procedure A Procedure is a written set of instructions that describes the approved and 
recommended	steps	for	a	particular	act	or	sequence	of	events.
Clinical Protocol A	Clinical	Protocol	is	an	agreed	statement	about	a	specific	clinical	issue,	
with	a	precise	sequence	of	activities	to	be	adhered	to,	with	little	scope	
for	variation.	Clinical	Protocols	are	usually	based	on	guidelines	and/or	
organisational consensus. 
Clinical Decision 
Support
Clinical Decision Support refers to the provision of clinical knowledge and 
patient	specific	information	to	help	clinicians	and	patients	make	decisions	
that enhance patient care.
Care Bundle A Care Bundle is a structured way of improving the processes of care and 
patient	outcomes:	a	small,	straightforward	set	of	evidence-based	practices	—	
generally	three	to	five	—	that,	when	performed	collectively	and	reliably,	have	
been proven to improve patient outcomes. 
Care Pathway A Care Pathway is a multidisciplinary care plan that outlines the main clinical 
interventions that are carried out by different healthcare practitioners for 
service	users	with	a	specific	condition	or	set	of	symptoms.	They	are	usually	
locally	agreed,	evidence-based	plans	that	can	incorporate	local	and	
national guidelines into everyday practice. 
Flowchart A	Flowchart	is	a	diagram	of	the	sequence	of	movements	or	actions	of	people	
or things involved in a complex system or activity.
Glossary of Terms
1	 This	definition	will	be	aligned	to	the	forthcoming	Health	Information	and	Patient	Safety	Bill.
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Algorithm Algorithms	provide	evidence-based	step-by-step	visual	interpretation	of	the	
decision	making	and/or	associated	actions	relating	to	a	particular	guidance	
area.	Notably	the	steps	within	an	algorithm	are	more	narrowly	defined	than	in	
a guideline.
Checklist A Checklist is a tool that condenses a large volume of information and allows 
for	systematic	verification	of	steps	or	practices.
Model of care A	Model	of	Care	is	a	multifaceted	concept,	which	broadly	defines	the	way	
health services are delivered. A model of care outlines best practice patient 
care delivery through the application of a set of service principles across 
identified	clinical	streams	and	patient	flow	continuums.
The broad objective of developing a model of care is ensuring people get 
the	right	care,	at	the	right	time,	by	the	right	team	and	in	the	right	place.
Clinician A Clinician is a health professional involved in clinical practice.
Standard A	Standard	is	a	definable	measure	against	which	existing	structures,	processes	
or outcomes can be compared.
Acronyms
CEU Clinical Effectiveness Unit. 
CHO Community	Health	Office.	
CMO Chief	Medical	Officer.
CPG Clinical Practice Guidance.
DoH Department	of	Health.
DoHC Department	of	Health	and	Children.
HIQA Health	Information	and	Quality	Authority.
HR Human	Resources.
HSE Health	Service	Executive.
HTA Health	Technology	Assessment.
IT Information Technology.
MHC Mental	Health	Commission.
NCEC National Clinical Effectiveness Committee.
PPPG Policies,	Procedures,	Protocols	and	Guidelines.	
See	Appendix	D	for	a	summary	of	definitions/nomenclature	currently	in	use.	
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The	purpose	of	this	document	is	to	provide	standards	for	healthcare	staff	developing	evidence-
based clinical practice guidance for health care.
What is Clinical Practice Guidance? 
Clinical	 practice	 guidance	 is	 defined	 as	 systematically	 developed	 statements	 or	 processes	
to	 assist	 clinician	 and	 patient	 decisions	 about	 appropriate	 health	 care	 for	 specific	 clinical	
circumstances,	 with	 the	 type	 of	 clinical	 practice	 guidance	 determined	 by	 evidence-based	
criteria	and	clinical	requirements.	Such	clinical	guidance	includes	clinical	policies,	procedures,	
protocols	and	guidelines.	Care	pathways,	clinical	decision	aids/tools,	care	bundles,	flowcharts,	
checklists	and	algorithms	can	form	components	of	policies,	procedures,	protocols	or	guidelines.
Does Clinical Practice Guidance improve patient care?
Clinical	effectiveness	is	a	key	component	of	patient	safety	and	quality.	The	integration	of	best	
evidence	in	service	provision,	through	clinical	effectiveness	processes	such	as	clinical	practice	
guidance,	promotes	healthcare	that	is	up	to	date,	effective	and	consistent.
The vision of the Standards for Clinical Practice Guidance is	 quality	 improvement	 for	 patient	
safety.	The	added	value	of	 standards	 for	clinical	practice	guidance	for	policy,	health	system,	
public and patients can include:
• Improving and optimising patient outcomes
• Evidence-based	practice	
• Standardisation of approach to avoid duplication
• Facilitation of audit: provides parameters for audit
• Reduction of variation in clinical practice
• Consistency of nomenclature 
• Improvement of methodological rigour.
Why do we need Standards for Clinical Practice Guidance?
In	clinical	practice,	there	are	different	types	of	guidance	that	vary	in	complexity	and	scope.	For	
example,	guidance	can	be	a	comprehensive	overarching	National	Clinical	Guideline	or	a	more	
specific	clinical	protocol.	Regardless	of	the	variation	in	scope	and	focus,	it	is	important	that	the	
development	 of	 all	 clinical	 guidance	 is	 underpinned	 by	 core	 standards	 using	 an	 evidence-
based	 approach,	 to	 assist	 clinician	 and	 patient	 decisions	 about	 appropriate	 healthcare	 for	
specific	clinical	circumstances.	
Through	 consistency	 in	 approach	and	 reduction	 in	 duplication,	 variation	 in	 practice	 can	 be	
reduced. Sharing of best practice will optimise use of health service resources and expertise.
NCEC approach to development of standards
The	standards	were	developed	by	the	NCEC,	informed	by	a	systematic	literature	review,	advice	
from an Expert Advisory Group and feedback from a public consultation process.
Aim: to publish standards for clinical practice guidance for healthcare providers.
Objectives: 
• Publish standards which will provide a standardised nomenclature and methodology for the 
development	of	evidence-based	clinical	practice	guidance	nationally.
• Ensure consistency of approach and minimise duplication in clinical practice guidance.
Purpose of this ‘Standards for Clinical Practice Guidance’ 
document1
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The Scope of the Standards for Clinical Practice Guidance includes Clinical Practice Guidance 
in	healthcare,	 spanning	 the	 full	multidisciplinary	 team.	This	 includes	all	healthcare	providers	 in	
the Republic of Ireland. The standards are applicable to healthcare in all settings e.g. acute 
care,	social	care,	mental	health,	care	of	the	elderly,	primary	care,	disabilities.
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Scope of the Standards for Clinical Practice Guidance 
• Clinical policies
• Clinical procedures 
• Clinical protocols
• Clinical guidelines
The	following	can	form	components	of	policies	/	procedures	/	protocols	/	guidelines:	
•	 Care	pathways,	clinical	decision	aids/tools,	care	bundles,	flowcharts	 
(Organisation of care; to support systems of care)
•	 Checklists,	algorithms	(Implementation)
The Standards for Clinical Practice Guidance	 include	 clinical	 policies,	 procedures,	 protocols	
and	guidelines.	Care	bundles,	care	pathways	and	clinical	decision	aids	can	 form	part	of	 the	
approach to organisation of care for clinical guidance. Checklists and algorithms can form 
part	of	 the	guidance	 implementation	toolbox.	These	are	 included	as	components	of	policies,	
procedures,	 protocols	 and	 guidelines	 rather	 than	 stand-alone	 clinical	 practice	 guidance.	
Models	of	care,	as	described	by	the	HSE	Clinical	Strategy	and	Programmes	Division	(Appendix	
D),	will	also	be	informed	by	the	standards.
There	 are	 existing	 regulatory	 frameworks	 which	 encompass	 requirements	 in	 relation	 to	 the	
development,	 implementation	 and	monitoring	 stages	 of	 clinical	 practice	 guidance,	 such	 as	
the National Standards for Safer Better Healthcare (HIQA,	2012)	and	the	Quality Framework for 
Mental Health Services	(MHC,	2007).	The	Standards for Clinical Practice Guidance are intended 
to support and complement these existing processes. 
It	is	expected	that	the	HSE	and	all	organisations	will	develop	all	new	and	updated	guidance	in	
line	with	these	standards.	Where	clinical	practice	guidance	is	already	in	place,	a	plan	to	review	
this	 guidance	 should	 be	 made,	 with	 key	 patient	 safety	 areas	 prioritised.	 Review	 of	 existing	
guidance	is	recommended	every	3	years,	or	sooner	if	required	by	law	or	new	evidence,	audit	or	
information	indicates	required	change.	
Outside scope
The Standards for Clinical Practice Guidance are applicable to healthcare processes which 
assist	 clinician	 and	 patient	 decisions	 about	 appropriate	 healthcare	 for	 specific	 clinical	
circumstances.	These	standards	are	not	intended	to	cover	operational	or	non-clinical	processes	
e.g.	specimen	transport,	clinical	waste	management,	HR	policies	etc.	
In	 exceptional	 circumstances,	 where	 interim	 clinical	 guidance	 is	 required	 on	 an	 emergency	
basis	 (e.g.	public	health	emergencies,	hazards	and	emerging	 infectious	 threats	such	as	Ebola	
virus),	 this	guidance	should	be	developed	by	experts,	based	on	the	best	available	evidence.	
If	 sustained	as	guidance	 following	 the	 initial	emergency,	 this	 interim	guidance	can	be	 further	
developed using the standards.
Scope2
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Organisations should put processes in place to implement and monitor these standards.
Formal	governance	arrangements	for	clinical	practice	guidance	at	local,	regional	and	national	
level should be established and documented by healthcare providers. This governance 
process	should	clearly	outline	quality	assurance	mechanisms,	specific	roles	and	responsibilities,	
accountability and authority. Clear processes for developing,	 approving,	 disseminating,	
implementing,	 monitoring,	 auditing	 and	 updating clinical practice guidance within the 
organisation needs to be clearly outlined and available for staff.
The	 Health	 Service	 Executive	 has	 established	 a	 National	 PPPG	 Steering	 Group	 for	 policies,	
procedures,	protocols	and	guidelines	(PPPG)	to	develop	a	framework	that	will	clearly	define	the	
process for the use and implementation of the NCEC Standards for Clinical Practice Guidance. 
A	governance	process,	standard	template,	staff	training	and	national	repository	for	HSE	CPGs	is	
also	planned	by	the	HSE.
The Standards for Clinical Practice Guidance provide a framework for assessment and audit. It is 
expected that the health system regulators will assess the corporate assurance arrangements in 
place to ensure effective implementation of these standards.
Monitoring and Implementation3
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An expert advisory group was established to provide advice and information to the NCEC in the 
development of the standards. The members of this group are listed below.
Organisation / Division (nominated by) Nominee
Clinical	Effectiveness	Unit,	
Department	of	Health
Dr Niamh O’Rourke (Chair)
HSE	Quality	Improvement	Division
(Dr Philip Crowley)
Ms Brid Boyce 
HSE	Mental	Health	Division
(Ms Anne O’Connor)
Ms Margaret Brennan 
HSE	Quality	Assurance	Verification	(QAV)	Division	
(Mr Patrick Lynch)
Dr Edwina Dunne
Independent	Hospital	Association	of	Ireland
(Ms Catherine Whelan) 
Dr Stephen Frohlich 
HSE	Social	Care	Division	
(Mr	Pat	Healy)
Dr Siobhan Kennelly
HSE	Clinical	Strategy	and	Programmes	Division	
(Dr Áine Carroll) 
Ms Aveen Murray 
HSE	Acute	Hospitals	Division
(Mr Liam Woods)
Ms Deirdre O’Keeffe
HSE	Primary	Care	Division
(Mr	John	Hennessy)
Ms	Virginia	Pye
Expert advisory group4
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The National Clinical Effectiveness Committee (NCEC) is a Ministerial committee established by 
the	Department	 of	 Health	 as	 part	 of	 the	 Patient	 Safety	 First	 Initiative	 to	provide	oversight	 for	
the	national	clinical	effectiveness	agenda	which	includes	National	Clinical	Guidelines,	National	
Clinical Audit and Clinical Practice Guidance. 
Membership of the committee is multidisciplinary and includes representatives from: the 
Health	 Information	 and	 Quality	 Authority,	 Mental	 Health	 Commission,	 Health	 and	 Social	
Care	 Regulatory	 Forum,	 Health	 Products	 Regulatory	 Authority,	 State	 Claims	 Agency,	 Forum	
of	 Postgraduate	 Training	 Bodies,	 Nursing	 and	 Midwifery	 Education	 Bodies,	 Forum	 of	 Hospital	
Group	CEOs,	HSE	Clinical	Programmes,	HSE	Quality	Improvement	Division,	HSE	Office	of	Nursing	
and	 Midwifery	 Services,	 National	 Office	 for	 Clinical	 Audit,	 Independent	 Hospital	 Association	
of	 Ireland,	Department	of	Health,	 Health	 Insurance	Council,	 Health	 Research	 Board	and	 two	
patient representatives. 
The NCEC Terms of Reference are to:
1. Provide strategic leadership for the national clinical effectiveness agenda.
2.	 Contribute	to	national	patient	safety	and	quality	improvement	agendas.
3. Publish Standards for Clinical Practice Guidance. 
4. Publish guidance for National Clinical Guidelines and National Clinical Audit.
5.	 Prioritise	and	quality-assure	National	Clinical	Guidelines	and	National	Clinical	Audit.
6. Commission National Clinical Guidelines and National Clinical Audit. 
7. Align National Clinical Guidelines and National Clinical Audit with implementation levers.
8. Report periodically on the implementation and impact of National Clinical Guidelines 
and the performance of National Clinical Audit. 
9.	 Establish	sub-committees	for	NCEC	work-streams.
10.	 Publish	an	Annual	Report.
The NCEC framework is outlined in Figure 1 below. Further information on the NCEC framework 
and	NCEC	documentation	 including	endorsement	and	quality	assurance	criteria	 for	National	
Clinical Guidelines and National Clinical Audit is available at: www.health.gov.ie/patient-safety/
ncec
Figure 1: NCEC framework 
National Clinical Effectiveness Committee5
National Clinical Effectiveness Committee (NCEC)
Patient Safety First Initiative
Ministerial committee 
(Supported by the Clinical Effectiveness Unit)
Suite 
National 
Clinical 
Guidelines
Standards
Clinical Practice 
Guidance
Suite
National 
Clinical Audit
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Clinical Effectiveness Processes
Clinical	effectiveness	is	a	key	component	of	patient	safety	and	quality.	The	integration	of	best	
evidence	 in	 service	 provision,	 through	 clinical	 effectiveness	 processes,	 promotes	 healthcare	
that	is	up	to	date,	effective	and	consistent.	Clinical	effectiveness	processes	include	guidelines,	
audit and clinical practice guidance.
This	 work	 emanates	 from	 a	 request	 by	 the	 Minister	 for	 Health	 that	 NCEC	 would	 develop	
standards for clinical practice guidance following the Report of the CMO into Portlaoise 
Perinatal	Deaths	(2014)	as	outlined	in	the	box	below.	The	development	of	Standards for Clinical 
Practice Guidance builds on existing frameworks such as Safer Better Healthcare	(HIQA	2012),	
Building a Culture of Patient Safety	(DoHC	2008)	and	the	Quality Framework for Mental Health 
Services	(MHC	2007).
Clinical Effectiveness 
Recommendation Responsible body 
R.19 The National Clinical 
Effectiveness 
Committee should 
develop standards 
for clinical practice 
guidance.
NCEC Standard	definitions	and	criteria	should	be	
developed in relation to the various forms of 
clinical	practice	guidance	such	as	guidelines,	
checklists,	procedures,	clinical	guidance,	
clinical protocols etc. This will ensure consistency 
of approach and utilisation of appropriate 
methodology to develop clinical practice 
guidance nationally.
National context
The	 Health	 Information	 and	 Quality	 Authority	 developed	National Standards for Safer Better 
Healthcare	in	2012	to	describe	what	a	high	quality,	safe	service	looks	like.	These	standards	are	an	
important driver for the implementation of clinical guidance as they set out the need for clinical 
decisions to be based on best available evidence and information; “to drive improvements in 
the	quality	and	 safety	of	healthcare	 it	 is	 important	 that	decisions,	 including	clinical	decisions,	
are based on the best available evidence and information”.
The	 report	 of	 the	Commission	on	 Patient	 Safety	and	Quality	Assurance,	Building a Culture of 
Patient Safety	(DoHC	2008)	and	the	Quality Framework for Mental Health Services	(MHC	2007)	
also	recommend	the	development	of	evidence-based	standards.	
It is important that the NCEC Standards for Clinical Practice Guidance are aligned with other 
national	 standards,	 initiatives	 and	 levers	 for	 implementation.	 The	 HSE	 work	 on	 PPPGs	 will	
complement and support the implementation of the NCEC Standards for Clinical Practice 
Guidance	 through	 a	 shared	 vision	 for	 evidence-based	 practice	 that	 reduces	 variation	 and	
duplication in clinical practice.
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The	existing	 regulatory	 and	policy	 frameworks	 encompass	 the	development,	 implementation	
and monitoring stages of clinical practice guidance and are summarised in the box below: 
National Standards for Safer Better Healthcare (HIQA, 2012) 
Standard	2.1.	Healthcare	reflects	national	and	international	evidence	of	what	is	known	to	achieve	best	
outcomes for service users. 
2.1.1	 Healthcare	that	is	delivered	according	to	policies,	guidelines,	protocols	and	care	pathways	
that are based on best available evidence. 
2.1.2		Use	of	National	Clinical	Guidelines	and	nationally	agreed	protocols,	care	bundles	and	care	
pathways where available.
2.1.6		An	evidence-based	process	for	the	development	of	policies,	guidelines,	protocols	and	care	
pathways. 
2.1.7		Support	for	and	facilitation	of,	the	workforce	in	making	decisions	based	on	the	best	available	
evidence. 
2.1.8  Support for healthcare professionals in making clinical decisions based on evidence which will 
maximise	benefits	to	service	users	and	minimise	unnecessary	treatment	and	care.
Standard	2.6.	Care	is	provided	through	a	model	of	service	designed	to	deliver	high	quality,	safe	and	
reliable healthcare.
2.6.2		Delivery	of	care	using	high	quality,	safe	and	reliable	models	of	service	delivery	that	have	the	
required	clinical	services,	meet	legislative	requirements	and	take	into	account	best	available	
evidence,	national	policies,	National	Clinical	Guidelines	if	available,	local	population	health	
needs and available resources.
Standard 7.2. Service	providers	have	arrangements	in	place	to	achieve	best	possible	quality	and	safety	
outcomes for service users for the money and resources used.
Building a Culture of Patient Safety (DoHC, 2008) (See appendix C for full text of recommendation)
5.5:	 Organisational	performance	indicators	and	targets	in	the	area	of	safety	and	quality.	
5.16:  Mandatory standards and key performance indicators. 
5.19:		Strong	emphasis	on	safety	and	quality	in	the	training	and	education	of	healthcare	
professionals.
6.6: Licencing should be linked to compliance with stated standards. 
6.9:	 HIQA	should	progress	urgently	the	development	of	standards	on	safety	and	quality.
6.11:  The regulations that determine the criteria for obtaining a licence should include 
implementation	of	evidence-based	practice.	
7.1:	 Production	of	evidence-based	information	and	guidance	for	use	in	policy	making,	system	
reform and individual patient and professional interactions. 
7.2: Evidence based service frameworks covering the major health conditions. 
7.4:	 Evidence	based	national	standards	should	be	developed,	with	multidisciplinary	input,	in	both	
primary	and	secondary	care	settings,	and	for	the	transition	between	care	settings.	
Quality Framework for Mental Health Services (MHC, 2007)
Standard	8.1	The	mental	health	service	is	delivered	in	accordance	with	evidence-based	codes	of	
practice,	policies	and	protocols.
8.1.3  The mental health service has uniform policies across service areas.
Standard 8.3 Corporate governance underpins the management and delivery of the mental health 
service.
8.3.2 The mental health service facilitates service user involvement at all stages of policy and 
service	development,	delivery	and	evaluation.
8.3.7 The mental health service implements a clinical governance system for improving clinical 
practice.
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Different	types	of	clinical	guidance	will	vary	in	complexity	and	scope,	with	the	choice	of	clinical	
practice	 guidance	model	 determined	 by	 evidence-based	 criteria	 and	 clinical	 requirements.	
Not	 all	 guidance	 requires	 the	 same	 pathway	 of	 development	 as	 an	 NCEC	National	 Clinical	
Guideline. Further information is available at http://health.gov.ie/patient-safety/ncec/national-
clinical-guidelines-2/
However,	regardless	of	the	variation	in	scope	and	focus,	it	is	important	that	the	development	of	
all	 clinical	guidance	 is	 underpinned	by	an	evidence-based	approach	and	quality	assurance	
measures	 to	 assist	 clinician	 and	 patient	 decisions	 about	 appropriate	 healthcare	 for	 specific	
clinical circumstances. 
In	 terms	 of	 clinical	 practice	 guidance,	 the	 health	 system	 as	 a	 whole	 is	 engaged	 with	 the	
development	of	processes	 to	 support	clinical	decision	making	at	 local,	 regional	and	national	
level	 as	 part	 of	 the	 quality	 improvement	 process.	 These	 processes	 involve	 the	 development	
of	policies,	protocols,	protocols	and	guidelines.	 The	methodology	 to	develop	 these	processes	
is variable and the provision of NCEC Standards for Clinical Practice Guidance will promote 
consistency	 of	 approach	 and	 utilisation	 of	 appropriate	 methodology	 to	 develop	 evidence-
based clinical practice guidance nationally. 
The	NCEC	sought	to	establish	the	extent	and	quality	of	the	evidence	internationally	on	clinical	
practice	 guidance	 in	 terms	 of	 effectiveness,	 rigour	 of	 development	 and	 quality	 assurance	
processes. A systematic literature review to support a framework for the development of 
standards	 for	 clinical	 practice	 guidance	 was	 completed	 in	 March	 2015.2	 In	 summary,	 the	
published evidence on effectiveness of clinical practice guidance is limited. The evidence 
review however provides a useful backdrop for the development by NCEC of Standards for 
Clinical Practice Guidance. 
The key messages from the literature included: 
• There	 is	a	 lack	of	 standardisation	of	 terminology,	methodology	and	quality	assurance	of	
clinical	practice	guidance	development,	implementation	and	evaluation	internationally.	
• There is a lack of evidence relating to cost effectiveness and clinical effectiveness of clinical 
practice guidance internationally. 
• Clinical	practice	guidance	must	be	evidence-based.
• Multi-stakeholder	 involvement	 is	 a	 key	 requirement	 for	 the	 effective	 development	 of	
guidance. 
• The	literature	revealed	barriers	and	facilitators	at	the	patient,	healthcare	professional,	team,	
organisational and health system level.
• Improvements to clinical guidance can be secured if barriers are tracked and a systems 
approach	is	taken	to	the	development,	implementation	and	evaluation	of	guidance.
The	 research	 team	 made	 recommendations	 pertaining	 to	 the	 development,	 management,	
implementation	 and	 evaluation	 of	 clinical	 guidance,	 including	 IT	 systems.	 A	 summary	 of	 the	
literature search strategy and results are outlined in Appendix A. 
Standards for Clinical Practice Guidance – rationale6
2	 Completed	by	a	research	team	based	in	UCC.	Literature	review	is	available	at:	http://health.gov.ie/patient-safety/ncec/
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These standards aim to promote consistency of clinical practice guidance across the country 
and	 avoid	 duplication.	 Synergies	 should	 be	 maximised	 across	 departments/organisations	 to	
optimise value for money and use of staff time and expertise. It is not in the interests of patient 
safety	 for	 individual	organisations/units	 to	develop	or	 implement	different	guidance	 for	 similar	
clinical circumstances. Where feasible and appropriate organisations should promote and 
utilise	national	clinical	practice	guidance	developed	in	line	with	these	standards,	to	avoid	any	
unnecessary	duplication,	encompassing	any	local	implementation	requirements	as	required.	
Prior	 to	commencing	the	development	of	clinical	practice	guidance,	 the	following	should	be	
established:
Existing CPGs Is	evidence-based	clinical	practice	guidance	already	available	for	this	topic/
clinical	question?	(local,	national	or	international).
Is	the	existing	CPG	up-to-date,	peer	reviewed	with	rigorous	methodology,	
generalisable	to	target	population	and	applicable	to	Ireland?	
Adapt/adopt Is this CPG being developed de novo or	being	adapted/adopted	from	existing	
guidance	nationally/internationally?	
Coverage/
geography 
Is	this	CPG	being	developed	as	national,	regional	(e.g.	hospital	group/community	
health	office)	or	local	guidance?	
Will the proposed CPG be relevant for use in a wider geographical area or wider 
clinical	area?	If	so,	wider	collaboration	needs	to	be	considered.	
 
In	general,	clinical	practice	guidance	should	not	vary	by	location,	although	the	
mechanism for local implementation may differ.
Multidisciplinary Does the CPG group membership include all relevant stakeholders and 
professional	groupings,	to	ensure	integrated	care	for	the	service	user?
Governance Has	a	governance	model	been	established	for	the	development,	approval,	
dissemination,	implementation,	monitoring,	audit,	updating	and	repository	of	
Clinical	Practice	Guidance	in	your	organisation?	
Model What	type	of	guidance	is	required	for	this	topic/clinical	question?	(E.g.	policy,	
procedure,	protocol,	guideline),	based	on	the	clinical	requirements.
Evidence base Have	you	established	access	to	a	library	or	clinical	librarian?	
Have	you	established	links	with	an	academic	partner/third	level	institution?	
The description of core components in this document provides a useful checklist for monitoring 
and audit.
Development of Clinical Practice Guidance7
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Core components 
A	number	of	core	components	form	the	basis	for	high	quality	evidence-based	clinical	practice	
guidance,	 which	 can	 be	 grouped	 into	 the	 four	 categories	 of	 governance,	 methodology,	
planning and implementation and communications.
Each	 of	 these	 components	 is	 described	 below,	 with	 a	 checklist	 of	 criteria	 to	 assist	 in	 the	
development of clinical practice guidance. All clinical practice guidance should meet these 
standards,	while	some	will	be	developed	to	a	higher	standard	as	 required	(denoted	complex	
CPGs below).
 Core components – Standards for evidence-based Clinical Practice Guidance
Governance Governance model
Audit,	monitoring,	review	&	evaluation	process
Service user and stakeholder involvement 
Knowledge management 
Methodology Clarity of scope and purpose
Evidence-based	
Planning & 
Implementation 
Resource implications
Planning	&	Implementation
Communications Communications
These	standards	will	be	reviewed	and	updated	by	the	NCEC	as	required.
The	current	version	is	available	on	www.health.gov.ie/patient-safety/ncec
Level of complexity
Clinical	practice	guidance	may	require	different	levels	of	complexity,	proportionate	to	the	type	
of	guidance.	For	example,	a	National	Clinical	Guideline	will	require	a	full	budget	impact	analysis	
and	 possibly	 a	 Health	 Technology	 Assessment	 (HTA),	 whereas	 a	 protocol	 may	 only	 require	
consideration	of	the	resources	required	to	develop	and	implement	the	protocol.	It	is	expected	
that	 all	 clinical	 practice	 guidance	will	 meet	 all	 minimum	 standards,	 whereas	more	 complex	
guidance	may	 require	additional	 rigour.	 The	standards	below	differentiate	between	minimum	
standards	and	more	rigorous	requirements	for	complex	guidance.	
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Figure 2: Core Components – Standards for Clinical Practice Guidance 
Governance 
model
Service	user/	
stakeholder 
involvement 
Knowledge 
management 
Resource 
implications 
Evidence  
based
Clarity of 
scope and 
purpose
Standards for
Clinical Practice
Guidance
Communications 
Planning	&	
Implementation  
Audit,	monitoring,	
review and 
evaluation 
15| National Clinical Effectiveness Committee | Standards for Clinical Practice Guidance
Standards for Clinical Practice Guidance
1. Clarity of scope and purpose
The	decision	making	approach	relating	to	type	of	guidance	required	(policy,	procedure,	
protocol,	guideline),	coverage	of	the	guidance	(national,	regional,	local)	and	applicable	
settings are described.
r
The	overall	objective(s)	of	the	clinical	guidance	are	specifically	described.	 r
The	clinical	question(s)	covered	by	the	guidance	are	specifically	described. r
The	target	users	and	the	population/patient	group	to	whom	the	guidance	is	meant	to	apply	
are	specifically	described.	 r
The	potential	for	improved	health	is	described	(e.g.	clinical	effectiveness,	patient	safety,	
quality	improvement,	health	outcomes,	quality	of	life,	quality	of	care). r
The	scope	of	the	CPG	is	clearly	described,	specifying	what	is	included	and	what	lies	outside	
the scope of the CPG. r
2. Governance model
Formal	governance	arrangements	for	clinical	practice	guidance	at	local,	regional	and	
national level are established and documented. r
Conflict	of	interest	statements	from	all	members	of	the	guidance	development	group	are	
documented,	with	a	description	of	mitigating	actions	if	relevant. r
The guidance has been reviewed by independent experts prior to publication. 
(as	required,	complex	CPGs).
3. Communications
A communication plan is developed to ensure effective communication and collaboration 
with all stakeholders throughout all stages. r
Plan and procedure for dissemination of the CPG is described. r
4. Service user and stakeholder involvement 
Stakeholder	identification	and	involvement:	The	guidance	development	group	includes	
individuals	from	all	relevant	stakeholders,	staff	and	professional	groups.	 r
Guidance	is	informed	by	the	identified	needs	and	priorities	of	service	users	and	stakeholders.	 r
The views and preferences of the target population have been sought and taken into 
consideration	(as	required).
There	is	service	user/lay	representation	on	guidance	development	team	(as	required).
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5. Evidence-based 
Systematic methods used to search for evidence are documented (for CPGs which are 
adapted/adopted	from	international	guidance,	their	methodology	is	appraised	and	
documented).
r
Critical	appraisal/analysis	of	evidence	using	validated	tools	is	documented	(the	strengths,	
limitations	and	methodological	quality	of	the	body	of	evidence	are	clearly	described).	 r
The	health	benefits,	side	effects	and	risks	have	been	considered	and	documented	in	
formulating the guidance. r
There is an explicit link between the clinical guidance and the supporting evidence. r
The	guidance/recommendations	are	specific	and	unambiguous.	 r
A	systematic	literature	review	and	Health	Technology	Assessment	(HTA)	has	been	undertaken	
(as	required,	complex	CPGs).
6. Knowledge management (Accessibility/sharing of best practice) 
The clinical guidance is easily accessible by all users e.g. CPG repository. r
Documented process for version control is provided. r
Copyright and permissions are sought and documented. r
7. Resource implications
The potential resource implications of developing and implementing the guidance are 
identified	e.g.	equipment,	education	&	training,	staff	time	and	research.	 r
Synergies	are	maximised	across	departments/organisations	to	avoid	duplication	and	to	
optimise value for money and use of staff time and expertise. r
Budget	impact	analysis	is	documented	(as	required,	complex	CPGs).
Literature	review	of	cost	effectiveness	is	documented	(as	required,	complex	CPGs).
8. Planning and Implementation 
Written	implementation	plan	is	provided	with	timelines,	identification	of	responsible	persons/
units and integration into service planning process. r
Barriers	and	facilitators	for	implementation	are	identified,	and	aligned	with	implementation	
levers. r
Information	and	support	is	available	for	staff	on	the	development	of	evidence-based	clinical	
practice guidance. r
There is collaboration across all stakeholders in the planning and implementation phases to 
optimise	patient	flow	and	integrated	patient	care. r
Education and training is provided for staff on the development and implementation of 
evidence-based	clinical	practice	guidance	(as	required,	complex	CPGs).
9. Audit, monitoring, review & evaluation process
Process for monitoring and continuous improvement is documented. r
Process	for	evaluation	of	implementation	and	clinical	effectiveness	is	specified.	 r
Audit	criteria	and	audit	process/plan	are	specified. r
Documented	process	for	revisions/updating	and	review,	including	timeframe	is	provided. r
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Appendix A: Systematic literature review
Key databases and grey literature sources were searched for evidence which evaluated 
guidance	(guidance,	pathway,	policy,	protocol,	bundle,	standard,	algorithm,	checklist,	decision	
aid,	 model	 of	 care),	 development,	 implementation	 and	 evaluation	 processes.	 A	 total	 of	 49	
papers were included in this systematic review (Table 1). Owing to the lack of level one evidence 
(i.e.	RCTs,	meta-analysis,	systematic	reviews	of	RCTs)	and	heterogeneity	of	methodologies	and	
outcomes,	 definitive	 conclusions	 could	 not	 be	 made	 as	 to	 the	 effectiveness	 of	 the	 various	
guidance	types	reviewed.	However,	the	analysis	of	papers	within	the	systematic	review	surmised	
that the implementation of guidance had a positive effect on patient outcomes and on the 
processes of care.
Table 1: Systematic	review	-	Category	of	papers	for	each	type	of	guidance	
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1 SR	of	SRs,	MAs	&	primary	studies 1 1
2 Meta –analysis (MAs) 2 2 4
3 SRs	&	MA 1 1 2 4
4 SRs of SRs 1 1
5 SR of primary studies 6 1 3 8 8 7 1 34
6 SR	&	expert	opinion 1 1
7 Papers on developing guidance inc. SRs 1 1 1 1 4
Total 9 4 4 13* 9 8 2 49
SR	=	systematic	review;	MA	=	meta-analysis
*Note: 15 papers reviewed on pathways but three papers related to the same body of evidence (Rotter 
et	al.,	2009;	2010;	2012)
Source: Hegarty, J., Savage E., Cornally, N., Byrne S., Henn P, Flynn M, McLoughlin K, Fitzgerald S, (2015). A 
systematic literature review to support a framework for the development of standards for clinical practice 
guidance. Department of Health; Dublin. Available at: http://health.gov.ie/patient-safety/ncec/clinical-
practice-guidance/
At	a	national	level,	evidence-based	guidance	can	be	provided	through:	statements	which	assist	
clinical	decision	making	(clinical	guidelines);	statements	of	 intent	(policy),	and	the	articulation	
of national standards against which practice can be benchmarked. The implementation 
of guidance in clinical practice can be supported through the use of implementation tools: 
protocols,	algorithms	and	checklists.	 In	 terms	of	national	approaches	 to	 the	organisation	and	
provision	of	evidence-based	care,	these	can	include	clinical	care	pathways	and	care	bundles.
Specific	 review	 questions	were	 included	 in	 the	 research	 objectives	 for	 the	 systematic	 review	
including;	 definitions	 of	 clinical	 practice	 guidance,	 core	 elements,	 decision	 criteria,	 quality	
criteria,	 impact,	 resources,	 updating	 processes,	 expertise	 required,	 format,	 strengths	 and	
weaknesses,	barriers	and	facilitators.	Table	2	summarises	the	papers	reviewed	for	each	of	these	
areas. 
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Table 2:	Number	of	papers	providing	data	on	each	question	addressed	in	the	systematic	literature	review	
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(n
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(n
=4
)
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(n
=1
5)
*
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(n
=9
)
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(n
=7
)
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re
(n
=2
)
TO
TA
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Q 1 Definitions 2 3 2 10 2 5 0 24
Q 2 Core elements 2 2 0 11 4 1 2 22
Q 3 Decision criteria 7 0 4 2 3 5 2 23
Q 4 Methodological processes** 8 1 1 6 6 6*** 1 29
Q 5 Quality	criteria****
(for 4 above)
7 0 0 3 1 2 0 13
&/or	assessment	of	quality	of	
studies in review paper
1 2 1 10 3 4 0 21
Q 6 (i) Impact i.e. outcomes 4 4 2 12 1 5 1 29
(ii) Method of impact 
validation
0 0 0 0 0 1 0 1
(iii) Implementation audit 
incl. outcome of 
implementation
1 1 0 0 0 4 0 6
Q 7 Resource	implications	(time/
cost)
3 0 3 5 1 3 1 16
Q 8 Updating processes 1 0 0 1 1 1 0 4
Q 9 Expertise needed 5 0 3 8 6 3 1 26
Q 10 Layout/format 4 0 3 4 4 5 0 20
Q 11 (i) Strengths 4 0 4 11 1 0 1 21
(ii) Weaknesses 6 0 3 3 0 1 0 13
Q 12 Barriers 3 2 3 6 4 1 2 21
Q 13 Facilitators 5 0 3 7 7 6 3 31
*Pathways:	Three	of	these	papers	relate	to	one	body	of	evidence	(Rotter	2009,	2010,	2011),	presented	as	
one paper in table.
**Methodological	processes:	Most	papers	addressed	development	processes,	some	of	which	also	
reported	on	implementation	&	evaluation.
***Protocols: One paper on protocols reported only on implementation process.
****Quality	criteria:	This	includes	use	of	a	grading	system	to	assess	the	quality	of	evidence	relevant	to	the	
development of guidance type.
Source: Hegarty, J., Savage E., Cornally, N., Byrne S., Henn P, Flynn M, McLoughlin K, Fitzgerald S, (2015). A 
systematic literature review to support a framework for the development of standards for clinical practice 
guidance. Department of Health; Dublin. Available at: http://health.gov.ie/patient-safety/ncec/clinical-
practice-guidance/
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Appendix B: Examples of International resources
Health Improvement Scotland: Methodology toolkit 
http://www.healthcareimprovementscotland.org/about_us/what_we_do/knowledge_
management/knowledge_management_resources/methodology_toolkit.aspx
Health Improvement Scotland: Evidence for healthcare improvement: evidence, advice, 
guidance and standards 
http://www.healthcareimprovementscotland.org/evidence.aspx
Australian Commission on Safety and Quality in Health Care: Clinical care standards 
http://www.safetyandquality.gov.au/our-work/clinical-care-standards/
National Institute for Health and Care Excellence (NICE), UK; 
• NICE pathways: http://pathways.nice.org.uk/ 
• NICE guidance https://www.nice.org.uk/guidance
• NICE standards and indicators https://www.nice.org.uk/standards-and-indicators
•	 NICE	guidelines:	 the	manual	(2014)	https://www.nice.org.uk/article/pmg20/chapter/1%20
Introduction%20and%20overview
• NICE Evidence Services https://www.evidence.nhs.uk/
AGREE - international tool to assess the quality and reporting of practice guidelines
http://www.agreetrust.org/agree-ii/ 
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Appendix C: Building a Culture of Patient Safety
The	 report	 of	 the	Commission	on	 Patient	 Safety	and	Quality	Assurance,	Building a Culture of 
Patient Safety (DoHC	2008)	recommends	the	development	of	evidence-based	standards:
Leadership and accountability 
R5.1  Key leadership roles must be assigned to designated professionals and agencies at national 
level for the purpose of providing strong clinical leadership to the system in the area of patient 
safety	and	quality.	Such	leadership	roles	must	include	advocacy	for	safety	and	quality,	the	
development and dissemination of patient safety knowledge and learning and the promotion of 
good practice.
R5.5 Organisational codes of governance must be implemented which clearly identify safety and 
quality	as	a	core	objective	and	which	specify	the	processes	by	which	these	objectives	will	
be	achieved.	Organisational	performance	in	these	areas	should	be	monitored,	through,	for	
example,	the	setting	of	specific	organisational	performance	indicators	and	targets	in	the	
area	of	safety	and	quality	and	the	requirement	for	regular	reports	via	internal	and	external	
accountability mechanisms on delivery against those targets. Patients should be provided with 
an accessible opportunity to contribute to such accountability mechanisms.
R5.16	 The	Board	must	review,	on	a	regular	basis,	the	systems	of	governance,	including	risk	
management	and	audit,	relating	to	healthcare	safety,	quality	and	performance.	This	should	
include: mandatory standards and key performance indicators. 
R5.19	 There	should	be	a	strong	emphasis	on	safety	and	quality	in	the	training	and	education	of	
healthcare professionals. All bodies responsible for the training and continuing development of 
healthcare	professionals	should	review	their	curricula	to	ensure	that	patient	safety	and	quality,	
including	technical	and	human	factors,	is	incorporated	into	the	modules.	
Organisational and Professional Regulatory Framework 
R6.6	 Licencing	should	be	linked	to	compliance	with	stated	standards,	enforceable	through	
inspection	and	imposition	of	sanctions	if	necessary.	The	sanctions	should	range	from	warnings,	
with	time	limits	for	compliance,	up	to	withdrawal	of	licence	either	for	a	specific	service	within	the	
hospital	or	the	hospital	itself	if	required.	
R6.9	 In	advance	of	the	introduction	of	legislation	providing	for	licensing,	HIQA	should	progress	
urgently	the	development	of	standards	on	safety	and	quality	to	be	applied	to	hospitals	and	all	
future	licensed	healthcare	facilities.	HIQA	should	also	be	asked	to	commence	work	immediately	
on	standards	in	respect	of	any	area	where	a	high	and	intermediate	risk	to	the	health	and/or	
welfare	of	patients	or	the	public	is	identified.	Subject	to	current	legal	provisions,	arrangements	
should be put in place by which private healthcare providers would voluntarily adhere to such 
standards,	agree	to	be	monitored	and	the	resulting	reports	published.	Private	health	insurers	
should	require	all	private	healthcare	facilities	to	adhere	to	the	standards	set	by	HIQA	where	such	
standards exist.
R6.11 The regulations that determine the criteria for obtaining a licence should include; 
implementation	of	evidence-based	practice.	
Quality Improvement and Learning Systems
R7.1	 A	leadership	role	in	relation	to	the	analysis	of	international	evidence	and	research,	and	to	the	
production	of	evidence-based	information	and	guidance	for	use	in	policy	making,	system	
reform and individual patient and professional interactions should be developed. 
R7.2	 A	rolling	programme	should	be	developed	by	the	Department	of	Health,	HIQA	and	the	HSE	to	
deliver	evidence-based	service	frameworks	covering	the	major	health	conditions	within	the	
public	healthcare	system,	similar	to	the	National	Service	Frameworks	model	in	the	UK.	Such	
frameworks should be reviewed periodically to encompass new evidence on effectiveness and 
performance. 
R7.4	 Evidence-based	national	standards	should	be	developed,	with	multidisciplinary	input,	in	both	
primary	and	secondary	care	settings,	and	for	the	transition	between	care	settings.	
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lin
ic
a
l P
ro
to
c
o
l
C
lin
ic
a
l p
ro
to
c
o
l: 
A
n
 a
g
re
e
d
 s
ta
te
m
e
n
t 
a
b
o
ut
	a
	s
p
e
c
ifi
c
	c
lin
ic
a
l	i
ss
ue
,	w
ith
	
a
	p
re
c
ise
	s
e
q
ue
nc
e
	o
f	a
c
tiv
iti
e
s	
to
	b
e
	a
d
he
re
d
	to
,	w
ith
	li
tt
le
	s
c
o
p
e
	
fo
r v
a
ria
tio
n
. C
lin
ic
a
l p
ro
to
c
o
ls 
a
re
 
us
ua
lly
	b
a
se
d
	o
n	
g
ui
d
e
lin
e
s	
a
nd
/o
r	
o
rg
a
n
isa
tio
n
a
l c
o
n
se
n
su
s.
 
Pr
o
to
c
o
l:	
Sp
e
c
ifi
c
	a
nd
	p
re
c
ise
	s
te
p
	
b
y 
st
e
p
 a
p
p
ro
a
c
h
 o
ft
e
n
 u
se
d
 t
o
 
su
p
p
o
rt
 t
h
e
 im
p
le
m
e
n
ta
tio
n
 o
f 
c
lin
ic
a
l g
u
id
e
lin
e
s 
w
h
ic
h
 a
re
 a
im
e
d
 a
t 
re
d
u
c
in
g
 v
a
ria
tio
n
s 
in
 c
lin
ic
a
l p
ra
c
tic
e
 
a
n
d
 o
u
tc
o
m
e
s 
(Il
o
tt
 e
t 
a
l.,
	2
01
0;
	E
b
b
e
n	
e
t 
a
l.,
	2
01
3)
.
Pr
o
to
c
o
l: 
A
	p
ro
to
c
o
l	i
s	
d
e
fin
e
d
	
a
s	
a
	w
rit
te
n	
p
la
n	
th
a
t	s
p
e
c
ifi
e
s	
p
ro
c
e
d
u
re
s 
to
 b
e
 fo
llo
w
e
d
 in
 
d
e
fin
e
d
	s
itu
a
tio
ns
;	a
	p
ro
to
c
o
l	
re
p
re
se
n
ts
 a
 s
ta
n
d
a
rd
 o
f c
a
re
 
th
a
t 
d
e
sc
rib
e
s 
a
n
 in
te
rv
e
n
tio
n
 
o
r s
e
t 
o
f i
n
te
rv
e
n
tio
n
s.
 P
ro
to
c
o
ls 
a
re
	m
o
re
	e
xp
lic
it	
a
nd
	s
p
e
c
ifi
c
	in
	
th
e
ir	
d
e
ta
il	
th
a
n	
g
ui
d
e
lin
e
s,
	th
e
y	
sp
e
c
ify
	w
ho
	d
o
e
s	
w
ha
t,	
w
he
n	
a
nd
	h
o
w
	(
A
n	
Bo
rd
	A
ltr
a
na
is	
20
00
).
	
Pr
o
to
c
o
ls 
a
re
 m
o
st
 t
yp
ic
a
lly
 u
se
d
 
w
h
e
n
 d
e
ve
lo
p
in
g
 in
st
ru
c
tio
n
s 
fo
r 
d
ru
g
	p
re
sc
rip
tio
n,
	d
isp
e
ns
in
g
	a
nd
	
a
d
m
in
ist
ra
tio
n,
	i.
e
.	d
ru
g
	p
ro
to
c
o
ls.
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)
H
SE
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G
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2 
C
lin
ic
a
l G
ui
d
e
lin
e
C
lin
ic
a
l g
ui
d
e
lin
e
: S
ys
te
m
a
tic
a
lly
 
d
e
ve
lo
p
e
d
	s
ta
te
m
e
nt
s,
	b
a
se
d
	o
n	
a
	
th
o
ro
ug
h	
e
va
lu
a
tio
n	
o
f	t
he
	e
vi
d
e
nc
e
,	t
o
	
a
ss
ist
 p
ra
c
tit
io
n
e
r a
n
d
 p
a
tie
n
t 
d
e
c
isi
o
n
s 
a
b
o
u
t 
a
p
p
ro
p
ria
te
 h
e
a
lth
c
a
re
 fo
r 
sp
e
c
ifi
c
	c
lin
ic
a
l	c
irc
um
st
a
nc
e
s,
	a
c
ro
ss
	
th
e
 e
n
tir
e
 c
lin
ic
a
l s
p
e
c
tr
u
m
.
G
ui
d
e
lin
e
:	A
	g
ui
d
e
lin
e
	is
	d
e
fin
e
d
	
a
s 
a
 p
rin
c
ip
le
 o
r c
rit
e
rio
n
 t
h
a
t 
g
u
id
e
s 
o
r d
ire
c
ts
 a
c
tio
n
 (
C
o
n
c
ise
 
O
xf
o
rd
 D
ic
tio
n
a
ry
 1
99
5)
. G
u
id
e
lin
e
 
d
e
ve
lo
p
m
e
nt
	e
m
p
ha
siz
e
s	
us
in
g
	
c
le
a
r e
vi
d
e
n
c
e
 fr
o
m
 t
h
e
 e
xi
st
in
g
 
lit
e
ra
tu
re
,	r
a
th
e
r	t
ha
n	
e
xp
e
rt
	
o
p
in
io
n	
a
lo
ne
,	a
s	
th
e
	b
a
sis
	fo
r	
a
d
vi
so
r	m
a
te
ria
ls	
(W
H
O
	2
00
9)
.
N
a
tio
na
l C
lin
ic
a
l G
ui
d
e
lin
e
N
C
EC
 N
a
tio
na
l C
lin
ic
a
l G
ui
d
e
lin
e
s:
 A
 
su
ite
	o
f	g
ui
d
e
lin
e
s	
th
a
t	m
e
e
t	s
p
e
c
ifi
c
	
q
ua
lit
y	
a
ss
ur
a
nc
e
	a
nd
	p
rio
rit
isa
tio
n	
c
rit
e
ria
 a
n
d
 t
h
a
t 
h
a
ve
 b
e
e
n
 
re
c
o
m
m
e
n
d
e
d
 b
y 
th
e
 N
a
tio
n
a
l C
lin
ic
a
l 
Ef
fe
c
tiv
e
n
e
ss
 C
o
m
m
itt
e
e
.
C
he
c
kl
is
t
C
he
c
kl
is
t: 
To
o
ls 
th
a
t 
c
o
n
d
e
n
se
 a
 la
rg
e
 
vo
lu
m
e
 o
f i
n
fo
rm
a
tio
n
 a
n
d
 a
llo
w
 fo
r 
sy
st
e
m
a
tic
	v
e
rifi
c
a
tio
n	
o
f	s
te
p
s	
o
r	
p
ra
c
tic
e
s	
(H
e
w
so
n	
e
t	a
l.,
	2
00
6;
	H
a
le
s	
e
t 
a
l.,
	2
00
8;
	W
H
O
	2
00
8)
.
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N
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H
IQ
A
 2
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C
C
 s
ys
te
m
a
tic
 re
vi
e
w
 2
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5
(p
p
 5
8-
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)
H
SE
 P
PP
G
 2
01
2 
Pa
th
w
a
y 
In
te
g
ra
te
d
 c
a
re
 p
a
th
w
a
y 
(c
lin
ic
a
l c
a
re
 
p
a
th
w
a
y)
: a
 m
u
lti
d
isc
ip
lin
a
ry
 c
a
re
 
p
la
n
 t
h
a
t 
o
u
tli
n
e
s 
th
e
 m
a
in
 c
lin
ic
a
l 
in
te
rv
e
n
tio
n
s 
th
a
t 
a
re
 c
a
rr
ie
d
 o
u
t 
b
y 
d
iff
e
re
n
t 
h
e
a
lth
c
a
re
 p
ra
c
tit
io
n
e
rs
 fo
r 
p
a
tie
nt
s	
w
ith
	a
	s
p
e
c
ifi
c
	c
o
nd
iti
o
n	
o
r	s
e
t	
o
f s
ym
p
to
m
s.
 T
h
e
y 
a
re
 u
su
a
lly
 lo
c
a
lly
 
a
g
re
e
d
,	e
vi
d
e
nc
e
d
-b
a
se
d
	p
la
ns
	th
a
t	
c
a
n
 in
c
o
rp
o
ra
te
 lo
c
a
l a
n
d
 n
a
tio
n
a
l 
g
u
id
e
lin
e
s 
in
to
 e
ve
ry
d
a
y 
p
ra
c
tic
e
. 
Pa
th
w
a
y:
	E
PA
	d
e
fin
iti
o
n:
	“
A
	c
o
m
p
le
x	
in
te
rv
e
n
tio
n
 fo
r t
h
e
 m
u
tu
a
l d
e
c
isi
o
n
 
m
a
ki
n
g
 a
n
d
 o
rg
a
n
isa
tio
n
 o
f c
a
re
 
p
ro
c
e
ss
e
s	
fo
r	a
	w
e
ll-
d
e
fin
e
d
	g
ro
up
	o
f	
p
a
tie
nt
s	
d
ur
in
g
	a
	w
e
ll-
d
e
fin
e
d
	p
e
rio
d
”	
(B
a
rb
ie
ri 
e
t 
a
l.,
	2
00
9)
.
A
 c
lin
ic
a
l p
a
th
w
a
y:
 
•
 I
n
c
lu
d
e
s 
a
 s
tr
u
c
tu
re
d
 m
u
lti
d
isc
ip
lin
a
ry
 
p
la
n
 o
f c
a
re
 (
m
a
n
d
a
to
ry
) 
•
 I
s 
u
se
d
 t
o
 t
ra
n
sla
te
 g
u
id
e
lin
e
s 
o
r 
e
vi
d
e
n
c
e
 in
to
 lo
c
a
l s
tr
u
c
tu
re
s
•
 D
e
ta
ils
 t
h
e
 s
te
p
s 
in
 a
 c
o
u
rs
e
 o
f 
tr
e
a
tm
e
nt
	o
r	c
a
re
	in
	a
	p
la
n,
	
p
a
th
w
a
y,
	a
lg
o
rit
hm
,	g
ui
d
e
lin
e
,	
p
ro
to
c
o
l o
r o
th
e
r '
in
ve
n
to
ry
 o
f 
a
c
tio
n
s'
•	
H
a
s	
tim
e
fra
m
e
s	
o
r	c
rit
e
ria
-b
a
se
d
	
p
ro
g
re
ss
io
n
 
•
 I
s 
a
im
e
d
 t
o
 s
ta
n
d
a
rd
ise
 c
a
re
 fo
r a
 
sp
e
c
ifi
c
	c
lin
ic
a
l	p
ro
b
le
m
,	p
ro
c
e
d
ur
e
	
o
r e
p
iso
d
e
 o
f h
e
a
lth
c
a
re
 in
 a
 
sp
e
c
ifi
c
	p
o
p
ul
a
tio
n.
A
n
 in
te
rv
e
n
tio
n
 is
 c
a
lle
d
 a
 c
lin
ic
a
l 
p
a
th
w
a
y	
if	
it	
m
e
e
ts
	th
e
	fi
rs
t	c
rit
e
ria
	
p
lu
s 
th
re
e
 o
u
t 
o
f t
h
e
 o
th
e
r f
o
u
r c
rit
e
ria
 
(K
in
sm
a
n
 e
t 
a
l.,
	2
01
2)
.
C
a
re
 b
un
d
le
A
 c
a
re
 b
un
d
le
 is
 a
 s
tr
u
c
tu
re
d
 w
a
y 
o
f i
m
p
ro
vi
n
g
 t
h
e
 p
ro
c
e
ss
e
s 
o
f c
a
re
 
a
nd
	p
a
tie
nt
	o
ut
c
o
m
e
s:
	a
	s
m
a
ll,
	
st
ra
ig
ht
fo
rw
a
rd
	s
e
t	o
f	e
vi
d
e
nc
e
-b
a
se
d
	
p
ra
c
tic
e
s	
—
	g
e
ne
ra
lly
	th
re
e
	to
	fi
ve
	—
	
th
a
t,	
w
he
n	
p
e
rf
o
rm
e
d
	c
o
lle
c
tiv
e
ly
	a
nd
	
re
lia
b
ly
,	h
a
ve
	b
e
e
n	
p
ro
ve
n	
to
	im
p
ro
ve
	
p
a
tie
nt
	o
ut
c
o
m
e
s.
	(
H
IQ
A
,	2
01
4	
)
Bu
nd
le
: A
 s
e
le
c
te
d
 s
e
t 
o
f i
n
te
rv
e
n
tio
n
s 
o
r p
ro
c
e
ss
e
s 
o
f c
a
re
 d
ist
ill
e
d
 fr
o
m
 
e
vi
d
e
n
c
e
 b
a
se
d
 p
ra
c
tic
e
 c
o
m
p
o
n
e
n
ts
 
th
a
t,	
w
he
n	
im
p
le
m
e
nt
e
d
	a
s	
a
	g
ro
up
,	
p
re
se
n
ts
 a
 m
o
re
 ro
b
u
st
 p
ic
tu
re
 o
f t
h
e
 
q
ua
lit
y	
c
a
re
	p
ro
vi
d
e
d
,	b
e
nc
hm
a
rk
s	
p
e
rf
o
rm
a
n
c
e
 a
n
d
 im
p
ro
ve
s 
p
a
tie
n
t 
o
ut
c
o
m
e
s.
	(
Be
rw
ic
k,
	2
00
6)
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A
lg
o
rit
hm
A
lg
o
rit
hm
: A
lg
o
rit
h
m
s 
p
ro
vi
d
e
 
e
vi
d
e
nc
e
	b
a
se
d
	s
te
p
-b
y-
st
e
p
	v
isu
a
l	
in
te
rp
re
ta
tio
n
 o
f t
h
e
 d
e
c
isi
o
n
 m
a
ki
n
g
 
a
nd
/o
r	a
ss
o
c
ia
te
d
	a
c
tio
ns
	re
la
tin
g
	to
	
a
 p
a
rt
ic
u
la
r g
u
id
a
n
c
e
 a
re
a
. N
o
ta
b
ly
 
th
e
 s
te
p
s 
w
ith
in
 a
n
 a
lg
o
rit
h
m
 a
re
 m
o
re
 
na
rro
w
ly
	d
e
fin
e
d
	th
a
n	
in
	a
	g
ui
d
e
lin
e
	
(B
e
itz
	e
t	a
l.,
	2
01
2)
.
St
a
nd
a
rd
St
a
nd
a
rd
:	A
	d
e
fin
a
b
le
	m
e
a
su
re
	a
g
a
in
st
	
w
hi
c
h	
e
xi
st
in
g
	s
tr
uc
tu
re
s,
	p
ro
c
e
ss
e
s	
o
r	
o
u
tc
o
m
e
s 
c
a
n
 b
e
 c
o
m
p
a
re
d
.
St
a
nd
a
rd
: A
 “
st
a
n
d
a
rd
” 
h
e
lp
s 
to
 c
re
a
te
 
a
 c
o
m
m
o
n
 u
n
d
e
rs
ta
n
d
in
g
 o
f t
h
e
 
st
a
n
d
a
rd
 o
f c
a
re
 s
e
rv
ic
e
 u
se
rs
 c
a
n
 
e
xp
e
c
t 
to
 re
c
e
iv
e
. A
 n
a
tio
n
a
l s
ta
n
d
a
rd
 
p
ro
vi
d
e
s 
a
 s
tr
a
te
g
ic
 a
p
p
ro
a
c
h
 a
n
d
 
a
 c
le
a
r b
e
n
c
h
m
a
rk
 w
ith
 t
h
e
 a
im
 o
f 
im
p
ro
vi
ng
	s
a
fe
ty
,	q
ua
lit
y	
a
nd
	re
lia
b
ilit
y	
w
ith
in
	th
e
	h
e
a
lth
	s
e
rv
ic
e
s	
(H
IQ
A
,	2
01
2)
.
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Fl
o
w
c
ha
rt
A
	d
ia
g
ra
m
	o
f	t
he
	s
e
q
ue
nc
e
	o
f	m
o
ve
m
e
nt
s	
o
r	a
c
tio
ns
	o
f	
p
e
o
p
le
 o
r t
h
in
g
s 
in
vo
lv
e
d
 in
 a
 c
o
m
p
le
x 
sy
st
e
m
 o
r a
c
tiv
ity
. 
(O
xf
o
rd
 d
ic
tio
n
a
ry
)
A
	fl
o
w
c
ha
rt
	o
r	fl
o
w
	d
ia
g
ra
m
	is
	a
	g
ra
p
hi
c
	re
p
re
se
nt
a
tio
n	
o
f	
a
	s
e
rie
s	
o
f	a
c
tiv
iti
e
s	
th
a
t	d
e
fin
e
	a
	p
ro
c
e
ss
.
(T
he
	im
p
ro
ve
m
e
nt
	g
ui
d
e
,	L
a
ng
le
y	
19
87
)
C
lin
ic
a
l d
e
c
is
io
n 
a
id
/t
o
o
l
C
lin
ic
a
l d
e
c
isi
o
n
 s
u
p
p
o
rt
 re
fe
rs
 t
o
 t
h
e
 p
ro
vi
sio
n
 o
f c
lin
ic
a
l 
kn
o
w
le
d
g
e
	a
nd
	p
a
tie
nt
	s
p
e
c
ifi
c
	in
fo
rm
a
tio
n	
to
	h
e
lp
	
c
lin
ic
ia
n
s 
a
n
d
 p
a
tie
n
ts
 m
a
ke
 d
e
c
isi
o
n
s 
th
a
t 
e
n
h
a
n
c
e
 
p
a
tie
n
t 
c
a
re
.
O
sh
e
ro
ff
	J
A
,	P
ife
r	E
A
,	T
e
ic
h	
JM
	2
00
5
(A
H
RQ
,	2
01
0)
M
o
d
e
l o
f c
a
re
 
A
	‘
m
o
d
e
l	o
f	c
a
re
’	
is	
a
	m
ul
tif
a
c
e
te
d
	c
o
nc
e
p
t,	
w
hi
c
h	
b
ro
a
d
ly
	d
e
fin
e
s	
th
e
	w
a
y	
he
a
lth
	s
e
rv
ic
e
s	
a
re
	d
e
liv
e
re
d
	
(Q
ue
e
ns
la
nd
	H
e
a
lth
	2
00
0)
.	A
	m
o
d
e
l	o
f	c
a
re
	o
ut
lin
e
s	
b
e
st
	
p
ra
c
tic
e
 p
a
tie
n
t 
c
a
re
 d
e
liv
e
ry
 t
h
ro
u
g
h
 t
h
e
 a
p
p
lic
a
tio
n
 o
f 
a
	s
e
t	o
f	s
e
rv
ic
e
	p
rin
c
ip
le
s	
a
c
ro
ss
	id
e
nt
ifi
e
d
	c
lin
ic
a
l	s
tr
e
a
m
s	
a
nd
	p
a
tie
nt
	fl
o
w
	c
o
nt
in
uu
m
s.
	(
W
a
ik
a
to
	H
e
a
lth
	B
o
a
rd
	
20
04
).
[H
SE
	C
lin
ic
a
l	S
tr
a
te
g
y	
a
nd
	P
ro
g
ra
m
m
e
s	
D
iv
isi
o
n]
	
M
o
d
e
l	o
f	c
a
re
	o
ve
rv
ie
w
	a
nd
	g
ui
d
e
lin
e
s	
(2
00
7)
D
e
p
a
rt
m
e
nt
	o
f	H
e
a
lth
,	W
	A
us
tr
a
lia
	
Th
e
 b
ro
a
d
 o
b
je
c
tiv
e
 o
f d
e
ve
lo
p
in
g
 a
 m
o
d
e
l o
f c
a
re
 is
 
e
ns
ur
in
g
	p
e
o
p
le
	g
e
t	t
he
	ri
g
ht
	c
a
re
,	a
t	t
he
	ri
g
ht
	ti
m
e
,	b
y	
th
e
 ri
g
h
t 
te
a
m
 a
n
d
 in
 t
h
e
 ri
g
h
t 
p
la
c
e
.
M
o
d
e
l	o
f	c
a
re
	o
ve
rv
ie
w
	a
nd
	g
ui
d
e
lin
e
s	
(2
00
7)
D
e
p
a
rt
m
e
nt
	o
f	H
e
a
lth
,	W
	A
us
tr
a
lia
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